150 related articles for article (PubMed ID: 35395332)
1. Knowledge Domain and Emerging Trends of Glucagon-Like Peptide 1 Receptor Agonists in Cardiovascular Research: A Bibliometric Analysis.
Shou X; Wang Y; Duan C; Yuan G; Wei N; Yang Y; Hu Y
Curr Probl Cardiol; 2023 Aug; 48(8):101194. PubMed ID: 35395332
[TBL] [Abstract][Full Text] [Related]
2. Global trends and focuses of GLP-1RA in renal disease: a bibliometric analysis and visualization from 2005 to 2022.
Meng Y; Wang Y; Fu W; Zhang M; Huang J; Wu H; Sun L
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3347-3361. PubMed ID: 37389601
[TBL] [Abstract][Full Text] [Related]
3. A visualization analysis of hotspots and frontiers of cardiovascular diseases with frailty.
Bao X; Chung LYF; Wen Y; Du Y; Sun Q; Wang Y
Front Public Health; 2022; 10():915037. PubMed ID: 36299762
[TBL] [Abstract][Full Text] [Related]
4. Knowledge domain and emerging trends of autophagy in cardiovascular research: A bibliometric analysis.
Lv M; Zhu X; You Y; Fan S; Chai R; Cheng T; Xue W; Shi S; Hu Y
Medicine (Baltimore); 2024 Jan; 103(2):e36811. PubMed ID: 38215119
[TBL] [Abstract][Full Text] [Related]
5. Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis.
Alfayez OM; Almohammed OA; Alkhezi OS; Almutairi AR; Al Yami MS
Cardiovasc Diabetol; 2020 Jun; 19(1):96. PubMed ID: 32571416
[TBL] [Abstract][Full Text] [Related]
6. Effect of Glucagon-like Peptide-1 Receptor Agonists on All-cause Mortality and Cardiovascular Outcomes: A Meta-analysis.
Peterson SC; Barry AR
Curr Diabetes Rev; 2018; 14(3):273-279. PubMed ID: 28413990
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-Like Peptide 1 Receptor Agonists (GLP1RA) and Sodium-glucose co-transporter-2 inhibitors (SGLT2i): Making a pragmatic choice in diabetes management.
Kalra S; Bhattacharya S; Kapoor N
J Pak Med Assoc; 2022 May; 72(5):989-990. PubMed ID: 35713074
[TBL] [Abstract][Full Text] [Related]
8. Global Trends in Research of Gouty Arthritis Over Past Decade: A Bibliometric Analysis.
Deng P; Wang S; Sun X; Qi Y; Ma Z; Pan X; Liang H; Wu J; Chen Z
Front Immunol; 2022; 13():910400. PubMed ID: 35757713
[TBL] [Abstract][Full Text] [Related]
9. Mapping Knowledge Landscapes and Emerging Trends of the Links Between Bone Metabolism and Diabetes Mellitus: A Bibliometric Analysis From 2000 to 2021.
Cheng K; Guo Q; Yang W; Wang Y; Sun Z; Wu H
Front Public Health; 2022; 10():918483. PubMed ID: 35719662
[TBL] [Abstract][Full Text] [Related]
10. An Update on Semaglutide Research: A Bibliometric Analysis and a Literature Review.
Dagli N; Kumar S; Ahmad R; Narwaria M; Haque M
Cureus; 2023 Oct; 15(10):e46510. PubMed ID: 37808605
[TBL] [Abstract][Full Text] [Related]
11. Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis.
Wu W; Ouyang Y; Zheng P; Xu X; He C; Xie C; Hong J; Lu N; Zhu Y; Li N
Front Cell Infect Microbiol; 2022; 12():1027448. PubMed ID: 36699721
[TBL] [Abstract][Full Text] [Related]
12. Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020.
Peng C; Kuang L; Zhao J; Ross AE; Wang Z; Ciolino JB
J Control Release; 2022 May; 345():625-645. PubMed ID: 35321827
[TBL] [Abstract][Full Text] [Related]
13. A bibliometric and visual analysis of low carbohydrate diet.
Lu G; Huang X; Lin C; Zou L; Pan H
Front Nutr; 2023; 10():1085623. PubMed ID: 36908904
[TBL] [Abstract][Full Text] [Related]
14. The intellectual base and research fronts of IL-37: A bibliometric review of the literature from WoSCC.
Qin YF; Ren SH; Shao B; Qin H; Wang HD; Li GM; Zhu YL; Sun CL; Li C; Zhang JY; Wang H
Front Immunol; 2022; 13():931783. PubMed ID: 35935954
[TBL] [Abstract][Full Text] [Related]
15. Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors.
Lin DS; Yu AL; Lo HY; Lien CW; Lee JK; Chen WJ
Diabetologia; 2022 Dec; 65(12):2032-2043. PubMed ID: 35945333
[TBL] [Abstract][Full Text] [Related]
16. Visualizing research trends and identifying hotspots of herbal components for treating cardiovascular diseases: A bibliometric analysis from 2000 to 2023.
Chen Y; Li WW; Bi SL; Zhang HM; Sun Z; Zuo YY; Xu L; Chen SQ
Medicine (Baltimore); 2024 Feb; 103(6):e35047. PubMed ID: 38335393
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
Li Y; Rosenblit PD
Curr Cardiol Rep; 2018 Sep; 20(11):113. PubMed ID: 30259238
[TBL] [Abstract][Full Text] [Related]
18. A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.
Miao L; Zhang J; Zhang Z; Wang S; Tang F; Teng M; Li Y
Front Immunol; 2022; 13():840956. PubMed ID: 35371087
[TBL] [Abstract][Full Text] [Related]
19. Knowledge mapping and research trends of IL-33 from 2004 to 2022: a bibliometric analysis.
Jin J; Wan Y; Shu Q; Liu J; Lai D
Front Immunol; 2023; 14():1158323. PubMed ID: 37153553
[TBL] [Abstract][Full Text] [Related]
20. Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021).
Yang S; Zhao S; Ye Y; Jia L; Lou Y
Front Immunol; 2022; 13():952546. PubMed ID: 36090978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
